0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Next Generation Diabetes Therapy and Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-35N12079
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Next Generation Diabetes Therapy and Drug Delivery Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Next Generation Diabetes Therapy and Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-35N12079
Report
October 2022
Pages:120
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Next Generation Diabetes Therapy and Drug Delivery estimated at US$ 2234.9 million in the year 2022, is projected to reach a revised size of US$ 7852.9 million by 2028, growing at a CAGR of 23.3% during the forecast period 2022-2028.

The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Next Generation Diabetes Therapy and Drug Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Next Generation Diabetes Therapy and Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Next Generation Diabetes Therapy and Drug Delivery market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Next Generation Diabetes Therapy and Drug Delivery Segment by Type

Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas

Next Generation Diabetes Therapy and Drug Delivery Segment by Application

Diagnostic/Clinics
ICUs
Home Healthcare
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Next Generation Diabetes Therapy and Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Next Generation Diabetes Therapy and Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Next Generation Diabetes Therapy and Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Diabetes Therapy and Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next Generation Diabetes Therapy and Drug Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Next Generation Diabetes Therapy and Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Next Generation Diabetes Therapy and Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Enteris BioPharma, Dexcom and Senseonics, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
2.2 Next Generation Diabetes Therapy and Drug Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2017-2022)
2.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Region (2023-2028)
2.5 Global Top Next Generation Diabetes Therapy and Drug Delivery Countries Ranking by Market Size
3 Next Generation Diabetes Therapy and Drug Delivery Competitive by Company
3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players
3.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2017-2022)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2017-2022)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021
3.5 Global Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Revenue by Type (2017-2022)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Revenue by Type (2023-2028)
5 Global Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)
8.2 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)
8.3 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)
8.4 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)
9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)
10.2 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)
10.3 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)
10.4 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.1.5 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.2.5 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.3.5 Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.3.6 Medtronic Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.4.5 Sanofi Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.5.5 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.5.6 Novo Nordisk Recent Developments
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Details
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.6.5 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.6.6 MannKind Corporation Recent Developments
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Details
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.7.5 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.7.6 Enteris BioPharma Recent Developments
11.8 Dexcom
11.8.1 Dexcom Company Details
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.8.5 Dexcom Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.8.6 Dexcom Recent Developments
11.9 Senseonics
11.9.1 Senseonics Company Details
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.9.5 Senseonics Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.9.6 Senseonics Recent Developments
11.10 Medtech
11.10.1 Medtech Company Details
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.10.5 Medtech Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
11.10.6 Medtech Recent Developments
11.11 Synertech
11.11.1 Synertech Company Details
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.11.5 Synertech Recent Developments
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Details
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.12.5 Zosano Pharma Recent Developments
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Details
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.13.5 Relmada Therapeutics Recent Developments
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.14.5 Eli Lilly and Company Recent Developments
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Details
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Products and Services
11.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.15.5 Transdermal Specialties Recent Developments
12 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
12.1 Next Generation Diabetes Therapy and Drug Delivery Market Trends
12.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
12.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
12.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Inhalable Insulin
    Table 3. Key Players of Oral Insulin
    Table 4. Key Players of Insulin Patches
    Table 5. Key Players of CGM Systems
    Table 6. Key Players of Artificial Pancreas
    Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
    Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2017-2022)
    Table 13. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)
    Table 14. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2021
    Table 15. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
    Table 16. Key Players Headquarters and Area Served
    Table 17. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
    Table 18. Date of Key Manufacturers Enter into Next Generation Diabetes Therapy and Drug Delivery Market
    Table 19. Mergers & Acquisitions, Expansion Plans
    Table 20. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 21. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2022)
    Table 22. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 23. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2023-2028)
    Table 24. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 25. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2022)
    Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2023-2028)
    Table 28. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
    Table 29. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 30. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 31. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 32. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 33. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 35. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
    Table 36. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 39. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 40. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 41. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 42. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
    Table 43. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
    Table 50. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
    Table 57. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 63. Johnson & Johnson Company Details
    Table 64. Johnson & Johnson Business Overview
    Table 65. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 66. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 67. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 68. Johnson & Johnson Recent Developments
    Table 69. Abbott Laboratories Company Details
    Table 70. Abbott Laboratories Business Overview
    Table 71. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 72. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 73. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 74. Abbott Laboratories Recent Developments
    Table 75. Medtronic Company Details
    Table 76. Medtronic Business Overview
    Table 77. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 78. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 79. Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 80. Medtronic Recent Developments
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 84. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 85. Sanofi Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 86. Sanofi Recent Developments
    Table 87. Novo Nordisk Company Details
    Table 88. Novo Nordisk Business Overview
    Table 89. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 90. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 91. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 92. Novo Nordisk Recent Developments
    Table 93. MannKind Corporation Company Details
    Table 94. MannKind Corporation Business Overview
    Table 95. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 96. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 97. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 98. MannKind Corporation Recent Developments
    Table 99. Enteris BioPharma Company Details
    Table 100. Enteris BioPharma Business Overview
    Table 101. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 102. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 103. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 104. Enteris BioPharma Recent Developments
    Table 105. Dexcom Company Details
    Table 106. Dexcom Business Overview
    Table 107. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 108. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 109. Dexcom Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 110. Dexcom Recent Developments
    Table 111. Senseonics Company Details
    Table 112. Senseonics Business Overview
    Table 113. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 114. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 115. Senseonics Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 116. Senseonics Recent Developments
    Table 117. Medtech Company Details
    Table 118. Medtech Business Overview
    Table 119. Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 120. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 121. Medtech Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
    Table 122. Medtech Recent Developments
    Table 123. Synertech Company Details
    Table 124. Synertech Business Overview
    Table 125. Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 126. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 127. Synertech Recent Developments
    Table 128. Zosano Pharma Company Details
    Table 129. Zosano Pharma Business Overview
    Table 130. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 131. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 132. Zosano Pharma Recent Developments
    Table 133. Relmada Therapeutics Company Details
    Table 134. Relmada Therapeutics Business Overview
    Table 135. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 136. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 137. Relmada Therapeutics Recent Developments
    Table 138. Eli Lilly and Company Company Details
    Table 139. Eli Lilly and Company Business Overview
    Table 140. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 141. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 142. Eli Lilly and Company Recent Developments
    Table 143. Transdermal Specialties Company Details
    Table 144. Transdermal Specialties Business Overview
    Table 145. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Services
    Table 146. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
    Table 147. Transdermal Specialties Recent Developments
    Table 148. Next Generation Diabetes Therapy and Drug Delivery Market Trends
    Table 149. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
    Table 150. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
    Table 151. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type: 2021 VS 2028
    Figure 2. Inhalable Insulin Features
    Figure 3. Oral Insulin Features
    Figure 4. Insulin Patches Features
    Figure 5. CGM Systems Features
    Figure 6. Artificial Pancreas Features
    Figure 7. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application: 2021 VS 2028
    Figure 8. Diagnostic/Clinics Case Studies
    Figure 9. ICUs Case Studies
    Figure 10. Home Healthcare Case Studies
    Figure 11. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
    Figure 12. Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Market Size 2017-2028 (US$ Million)
    Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region in 2017 VS 2022
    Figure 16. Global Top 10 Next Generation Diabetes Therapy and Drug Delivery Countries Ranking by Market Size (US$ Million) in 2021
    Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2021
    Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021
    Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021
    Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 22. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 23. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)
    Figure 24. U.S. Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 25. Canada Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 26. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021
    Figure 27. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 28. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 29. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)
    Figure 30. Germany Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 31. France Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 32. U.K. Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 33. Italy Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 34. Russia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021
    Figure 36. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Region (2017-2028)
    Figure 39. China Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 40. Japan Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 41. South Korea Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 42. India Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 43. Australia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 44. Taiwan Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 45. Indonesia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 46. Thailand Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 47. Malaysia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 48. Philippines Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 49. Vietnam Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 50. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021
    Figure 51. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 52. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 53. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)
    Figure 54. Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 55. Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 56. Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021
    Figure 58. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)
    Figure 61. Turkey Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 63. UAE Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 66. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 67. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 68. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 69. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 70. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 71. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 72. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 73. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 74. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 75. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 76. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 77. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 78. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS